Evidence map›Paper›PMID 40002301›Full record

ArticleCancers2025

Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research Recommendations in Women with Breast Cancer.

Vanessa Pachón Olmos, Marina Pollán, Nerea Fernández de Larrea-Baz, Julia Fernández-Morata, Emma Ruiz-Moreno, Javier García-Pérez, Adela Castelló, María Ángeles Sierra, Pilar Lucas, Isabel Alonso-Ledesma and 14 more

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Vanessa Pachón OlmosPreventive Medicine Department, La Paz-Carlos III-Cantoblanco University Hospital, Po de la Castellana 261, 28046 Madrid, Spain.ORCID 0000-0001-5139-9398
Marina PollánCancer and Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III (ISCIII), Avda. Monforte de Lemos 5, 28029 Madrid, Spain.ORCID 0000-0002-4328-1565
Nerea Fernández de Larrea-BazCancer and Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III (ISCIII), Avda. Monforte de Lemos 5, 28029 Madrid, Spain.
Julia Fernández-MorataPrograma de Doctorado en Ciencias Biomédicas y Salud Pública IMIENS-UNED-ISCIII, Escuela Internacional de Doctorado de la Universidad Nacional de Educación a Distancia (EIDUNED), Avda. Monforte de Lemos 5, 28029 Madrid, Spain.
Emma Ruiz-MorenoCancer and Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III (ISCIII), Avda. Monforte de Lemos 5, 28029 Madrid, Spain.ORCID 0000-0003-3662-4440
Javier García-PérezCancer and Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III (ISCIII), Avda. Monforte de Lemos 5, 28029 Madrid, Spain.ORCID 0000-0003-0300-1810
Adela CastellóCancer and Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III (ISCIII), Avda. Monforte de Lemos 5, 28029 Madrid, Spain.ORCID 0000-0002-1308-9927
María Ángeles SierraCancer and Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III (ISCIII), Avda. Monforte de Lemos 5, 28029 Madrid, Spain.ORCID 0000-0003-1765-8733
Pilar LucasCancer and Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III (ISCIII), Avda. Monforte de Lemos 5, 28029 Madrid, Spain.
Isabel Alonso-LedesmaCancer and Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III (ISCIII), Avda. Monforte de Lemos 5, 28029 Madrid, Spain.ORCID 0000-0001-7272-2561
Agostina StradellaMultidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, Idibell, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Spain.ORCID 0000-0002-2307-8869
Blanca CantosDepartment of Medical Oncology, Hospital Universitario Puerta de Hierro, C. Joaquín Rodrigo, 1, 28222 Majadahonda, Spain.ORCID 0000-0003-2105-1213
Teresa Ramón Y CajalConsulta de Cáncer Familiar, Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quintí, 89, Horta-Guinardó, 08025 Barcelona, Spain.ORCID 0000-0003-3490-3585
Marta SantistebanBreast Cancer Unit, Department of Medical Oncology, Clínica Universidad de Navarra, IdiSNA, Av. de Pío XII, 36, 31008 Pamplona, Spain.ORCID 0000-0003-0625-686X
Miguel Ángel SeguíDepartment of Medical Oncology, Consorcio Hospital Universitario Parc Tauli, Parc Taulí, 1, 08208 Sabadell, Spain.ORCID 0000-0002-5103-6746
Ana Santaballa BertránMedical Oncology Department, La Fe Health Research Institute (IISLaFe), La Fe University Hospital, Avinguda de Fernando Abril Martorell, 106, Quatre Carreres, 46026 Valencia, Spain.
Mónica GranjaDepartment of Medical Oncology, Hospital Universitario Clínico San Carlos, Calle Prof Martín Lagos, S/N, Moncloa-Aravaca, 28040 Madrid, Spain.
Julia Camps-HerreroDepartment of Radiology, Hospital Universitario de La Ribera, Ctra. Corbera km 1, 46600 Alzira, Spain.ORCID 0000-0002-8061-6272
Sabela RecaldeMultidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia-Hospitalet, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Spain.
Miriam MendezDepartment of Medical Oncology, Hospital Universitario Puerta de Hierro, C. Joaquín Rodrigo, 1, 28222 Majadahonda, Spain.
Nuria Calvo VergesConsulta de Cáncer Familiar, Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quintí, 89, Horta-Guinardó, 08025 Barcelona, Spain.
Beatriz Pérez-GómezCancer and Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III (ISCIII), Avda. Monforte de Lemos 5, 28029 Madrid, Spain.ORCID 0000-0002-4299-8214
Roberto Pastor-BarriusoCancer and Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III (ISCIII), Avda. Monforte de Lemos 5, 28029 Madrid, Spain.
Virginia LopeCancer and Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III (ISCIII), Avda. Monforte de Lemos 5, 28029 Madrid, Spain.ORCID 0000-0002-6986-4021

Funding

Instituto de Salud Carlos III AESI PI15CIII/00029
6 · The paper itself

Abstract

BACKGROUND/

objectivesThe 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations benefit primary prevention and survivor outcomes. This study evaluated the adherence to these recommendations during the year prior to breast cancer diagnosis and identified related clinical and sociodemographic factors.

methodsA total of 915 patients with breast cancer were recruited from eight hospitals in four regions of Spain. The participants completed an epidemiologic questionnaire and a food frequency questionnaire. The compliance with the WCRF/AICR recommendations was assessed using a standardized score based on seven recommendations. Standardized prevalences and standardized prevalence ratios (SPRs) for moderate and high adherence were calculated based on participant characteristics using binary and multinomial logistic regression models.

resultsThe mean adherence was 3.5 points out of 7. The recommendations with the best and worst adherence were avoiding sugar-sweetened drinks (54.4% adherence) and maintaining a fiber-rich diet (4.4% consumed ≥30 g/day). The overall adherence was better in women aged ≥60 years (SPR = 1.55; 95% CI = 1.09-2.22), and worse in those with a caloric intake ≥2000 kcal/day (SPR = 0.48; 95% CI = 0.37-0.62) or ≥2 comorbidities (SPR = 0.66; 95% CI = 0.49-0.89). The adherence to maintaining a healthy weight was worse in those with ≥2 comorbidities and stage III-IV tumors. The physical activity adherence was worse in working women and those with ≥2 comorbidities. The alcohol restriction adherence was worse in smokers. Younger women, smokers and those with a low calorie intake were less adherent to the fruit/vegetable recommendation. The consumption of fiber and limited consumption of red/processed meat adherence was poor in all the subgroups. The adherence to a limited consumption of fast food and sugary drinks was worse in younger women and high-calorie-diet consumers.

conclusionsThe differences in the adherence to recommendations according to patient characteristics justify the design of personalized interventions for breast cancer patients.

Indexed as

breast cancer patientscancer prevention recommendationscompliancehealth behaviorshealthy lifestylelifestyle recommendationsWCRF/AICR guidelines

Identifiers

PMID40002301
PMCPMC11853811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.